Anthracycline cardiotoxicity is not only left ventricular systolic dysfunction

被引：1
|
作者：
Szmit, Sebastian [1 ,2 ]
机构：
[1] Europejskie Ctr Zdrowia, Ctr Med Ksztalcenia Podyplomowego, Klin Krazenia Plucnego & Chorob Zakrzepowo Zatoro, Otwock, Poland
[2] Europejskie Ctr Zdrowia, Ctr Med Ksztalcenia Podyplomowego, Klin Onkol, Otwock, Poland
来源：
KARDIOLOGIA POLSKA | 2013年 / 71卷 / 07期
关键词：
ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD-CANCER; INDUCED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; BREAST-CANCER; LONG-TERM; DOXORUBICIN THERAPY; RECEPTOR BLOCKER; HEART-FAILURE; CHEMOTHERAPY;
D O I：
10.5603/KP.2013.0155
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：691 / 694
页数：4
相关论文
共 50 条
  • [1] Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline cardiotoxicity?
    Patel, Chetan D.
    Balakrishnan, Vijay Babu
    Kumar, Lalit
    Naswa, Niraj
    Malhotra, Arun
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2010, 13 (03): : 233 - 237
  • [2] A Historical Perspective of Anthracycline Cardiotoxicity
    Ewer, Michael S.
    Von Hoff, Daniel D.
    Benjamin, Robert S.
    HEART FAILURE CLINICS, 2011, 7 (03) : 363 - +
  • [3] Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction
    Shugg, Tyler
    Nguyen, Tk
    Hua, Xuesi
    Richards, Blair
    Rae, James
    Dess, Robert
    Perry, Daniel
    Kay, Bradley
    Hayek, Salim S.
    Leja, Monika
    Luzum, Jasmine A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2025, 30
  • [4] Prevention of Anthracycline-Induced Cardiotoxicity
    Vejpongsa, Pimprapa
    Yeh, Edward T. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (09) : 938 - 945
  • [5] Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity
    Ohtani, Kisho
    Fujino, Takeo
    Ide, Tomomi
    Funakoshi, Kouta
    Sakamoto, Ichirou
    Hiasa, Ken-ichi
    Higo, Taiki
    Kamezaki, Kenjiro
    Akashi, Koichi
    Tsutsui, Hiroyuki
    CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (06) : 600 - 611
  • [6] Anthracycline Chemotherapy and Cardiotoxicity
    McGowan, John V.
    Chung, Robin
    Maulik, Angshuman
    Piotrowska, Izabela
    Walker, J. Malcolm
    Yellon, Derek M.
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (01) : 63 - 75
  • [7] Cardioprotection strategies for anthracycline cardiotoxicity
    Moreno-Arciniegas, Andrea
    Cadiz, Laura
    Galan-Arriola, Carlos
    Clemente-Moragon, Agustin
    Ibanez, Borja
    BASIC RESEARCH IN CARDIOLOGY, 2025, 120 (01) : 71 - 90
  • [8] Monitoring for Chemotherapy-Related Cardiotoxicity in the Form of Left Ventricular Systolic Dysfunction: A Review of Current Recommendations
    Stone, Jeremy R.
    Kanneganti, Radha
    Abbasi, Muhannad
    Akhtari, Mojtaba
    JCO ONCOLOGY PRACTICE, 2021, 17 (05) : 228 - +
  • [9] Prediction of Anthracycline-Induced Left Ventricular Dysfunction by Cardiac Troponins
    Thigpen, S. Calvin
    Geraci, Stephen A.
    SOUTHERN MEDICAL JOURNAL, 2012, 105 (12) : 659 - 664
  • [10] Anthracycline-related cardiotoxicity in childhood cancer survivors
    Lipshultz, Steven E.
    Karnik, Ruchika
    Sambatakos, Peter
    Franco, Vivian I.
    Ross, Samuel W.
    Miller, Tracie L.
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (01) : 103 - 112
12345